| Year |
Citation |
Score |
| 2024 |
Wamhoff EC, Ronsard L, Feldman J, Knappe GA, Hauser BM, Romanov A, Case JB, Sanapala S, Lam EC, Denis KJS, Boucau J, Barczak AK, Balazs AB, Diamond MS, Schmidt AG, et al. Enhancing antibody responses by multivalent antigen display on thymus-independent DNA origami scaffolds. Nature Communications. 15: 795. PMID 38291019 DOI: 10.1038/s41467-024-44869-0 |
0.365 |
|
| 2023 |
Joshi LR, Gálvez NMS, Ghosh S, Weiner DB, Balazs AB. Delivery platforms for broadly neutralizing antibodies. Current Opinion in Hiv and Aids. PMID 37265268 DOI: 10.1097/COH.0000000000000803 |
0.42 |
|
| 2023 |
Nugent C, Abul Y, White EM, Shehadeh F, Kaczynski M, Oscar Felix L, Ganesan N, Oyebanji OA, Vishnepolskiy I, Didion EM, Paxitzis A, Sheehan ML, Chan PA, Pfeifer WM, Dickerson E, ... ... Balazs AB, et al. Second monovalent SARS-CoV-2 mRNA booster restores Omicron-specific neutralizing activity in both nursing home residents and health care workers. Vaccine. PMID 37117056 DOI: 10.1016/j.vaccine.2023.04.034 |
0.346 |
|
| 2023 |
Luthuli B, Gounder K, Deymier MJ, Dong KL, Balazs AB, Mann JK, Ndung'u T. Generation and characterization of infectious molecular clones of transmitted/founder HIV-1 subtype C viruses. Virology. 583: 14-26. PMID 37084644 DOI: 10.1016/j.virol.2023.04.001 |
0.32 |
|
| 2023 |
Nugent C, Abul Y, White E, Shehadeh F, Kaczynski M, Felix LO, Ganesan N, Oyebanji OA, Vishnepolskiy I, Didion EM, Paxitzis A, Sheehan ML, Mylonakis E, Wilson BM, Balazs AB, et al. Second monovalent SARS-CoV-2 mRNA booster restores Omicron-specific neutralizing activity in both nursing home residents and health care workers. Medrxiv : the Preprint Server For Health Sciences. PMID 36747765 DOI: 10.1101/2023.01.22.23284881 |
0.347 |
|
| 2023 |
Canaday DH, Oyebanji OA, White EM, Bosch J, Nugent C, Vishnepolskiy I, Abul Y, Didion EM, Paxitzis A, Sundheimer N, Ragavapuram V, Wilk D, Keresztesy D, Cao Y, St Denis K, ... ... Balazs AB, et al. SARS-CoV-2 Antibody Responses to the Ancestral SARS-CoV-2 Strain and Omicron BA.1 and BA.4/BA.5 Variants in Nursing Home Residents After Receipt of Bivalent COVID-19 Vaccine - Ohio and Rhode Island, September-November 2022. Mmwr. Morbidity and Mortality Weekly Report. 72: 100-106. PMID 36701254 DOI: 10.15585/mmwr.mm7204a4 |
0.321 |
|
| 2022 |
Bartsch YC, Chen JW, Kang J, Burns MD, St Denis KJ, Sheehan ML, Davis JP, Edlow AG, Balazs AB, Yonker LM, Alter G. BNT162b2 induces robust cross-variant SARS-CoV-2 immunity in children. Npj Vaccines. 7: 158. PMID 36463314 DOI: 10.1038/s41541-022-00575-w |
0.34 |
|
| 2022 |
Hauser BM, Feldman J, Sangesland M, Ronsard L, St Denis KJ, Sheehan ML, Cao Y, Boucau J, Windsor IW, Cheng AH, Vu ML, Cardoso MR, Kannegieter T, Balazs AB, Lingwood D, et al. Cross-reactive SARS-CoV-2 epitope targeted across donors informs immunogen design. Cell Reports. Medicine. 100834. PMID 36423634 DOI: 10.1016/j.xcrm.2022.100834 |
0.445 |
|
| 2022 |
Wamhoff EC, Ronsard L, Feldman J, Hauser BM, Knappe GA, Romanov A, Lam E, St Denis K, Balazs AB, Schmidt A, Lingwood D, Bathe M. Enhancing antibody responses by multivalent antigen display on thymus-independent DNA origami scaffolds. Biorxiv : the Preprint Server For Biology. PMID 36032975 DOI: 10.1101/2022.08.16.504128 |
0.377 |
|
| 2022 |
Hauser BM, Sangesland M, Lam EC, Feldman J, Balazs AB, Lingwood D, Schmidt AG. Humoral responses to the SARS-CoV-2 spike and receptor binding domain in context of pre-existing immunity confer broad sarbecovirus neutralization. Frontiers in Immunology. 13: 902260. PMID 35990628 DOI: 10.3389/fimmu.2022.902260 |
0.371 |
|
| 2022 |
Brady JM, Phelps M, MacDonald SW, Lam EC, Nitido A, Parsons D, Boutros CL, Deal CE, Garcia-Beltran WF, Tanno S, Natarajan H, Ackerman ME, Vrbanac VD, Balazs AB. Antibody-mediated prevention of vaginal HIV transmission is dictated by IgG subclass in humanized mice. Science Translational Medicine. 14: eabn9662. PMID 35895834 DOI: 10.1126/scitranslmed.abn9662 |
0.751 |
|
| 2022 |
Atyeo C, Shook LL, Nziza N, Deriso EA, Muir MC, Medina Baez MA, Lima MRS, Demidkin MS, Brigida MS, De Guzman RM, Burns MMD, Balazs AB, Fasano A, Yonker LM, Gray KJ, et al. COVID-19 booster dose induces robust antibody response in pregnant, lactating, and nonpregnant women. American Journal of Obstetrics and Gynecology. PMID 35868417 DOI: 10.1016/j.ajog.2022.07.014 |
0.304 |
|
| 2022 |
Atyeo CG, Shook LL, Brigida S, De Guzman RM, Demidkin S, Muir C, Akinwunmi B, Baez AM, Sheehan ML, McSweeney E, Burns MD, Nayak R, Kumar MK, Patel CD, Fialkowski A, ... ... Balazs AB, et al. Maternal immune response and placental antibody transfer after COVID-19 vaccination across trimester and platforms. Nature Communications. 13: 3571. PMID 35764643 DOI: 10.1038/s41467-022-31169-8 |
0.348 |
|
| 2022 |
Burns MD, Boribong BP, Bartsch YC, Loiselle M, St Denis KJ, Sheehan ML, Chen JW, Davis JP, Lima R, Edlow AG, Fasano A, Balazs AB, Alter G, Yonker LM. Durability and Cross-Reactivity of SARS-CoV-2 mRNA Vaccine in Adolescent Children. Vaccines. 10. PMID 35455241 DOI: 10.3390/vaccines10040492 |
0.335 |
|
| 2022 |
Casazza JP, Cale EM, Narpala S, Yamshchikov GV, Coates EE, Hendel CS, Novik L, Holman LA, Widge AT, Apte P, Gordon I, Gaudinski MR, Conan-Cibotti M, Lin BC, Nason MC, ... ... Balazs AB, et al. Safety and tolerability of AAV8 delivery of a broadly neutralizing antibody in adults living with HIV: a phase 1, dose-escalation trial. Nature Medicine. PMID 35411076 DOI: 10.1038/s41591-022-01762-x |
0.698 |
|
| 2022 |
Barmettler S, DiGiacomo DV, Yang NJ, Lam T, Naranbhai V, Dighe AS, Burke KE, Blumenthal KG, Ling M, Hesterberg PE, Saff RR, MacLean J, Ofoman O, Berrios C, St Denis KJ, ... ... Balazs A, et al. Response to SARS-CoV-2 Initial Series and Additional Dose Vaccine in Patients with Predominant Antibody Deficiency. The Journal of Allergy and Clinical Immunology. in Practice. PMID 35381395 DOI: 10.1016/j.jaip.2022.03.017 |
0.386 |
|
| 2022 |
Hauser BM, Sangesland M, St Denis KJ, Lam EC, Case JB, Windsor IW, Feldman J, Caradonna TM, Kannegieter T, Diamond MS, Balazs AB, Lingwood D, Schmidt AG. Rationally designed immunogens enable immune focusing following SARS-CoV-2 spike imprinting. Cell Reports. 38: 110561. PMID 35303475 DOI: 10.1016/j.celrep.2022.110561 |
0.388 |
|
| 2022 |
Naranbhai V, Nathan A, Kaseke C, Berrios C, Khatri A, Choi S, Getz MA, Tano-Menka R, Ofoman O, Gayton A, Senjobe F, Denis KJS, Lam EC, Garcia-Beltran WF, Balazs AB, et al. T cell reactivity to the SARS-CoV-2 Omicron variant is preserved in most but not all prior infected and vaccinated individuals. Medrxiv : the Preprint Server For Health Sciences. PMID 35018386 DOI: 10.1101/2022.01.04.21268586 |
0.315 |
|
| 2022 |
Garcia-Beltran WF, St Denis KJ, Hoelzemer A, Lam EC, Nitido AD, Sheehan ML, Berrios C, Ofoman O, Chang CC, Hauser BM, Feldman J, Roederer AL, Gregory DJ, Poznansky MC, Schmidt AG, ... ... Balazs AB, et al. mRNA-based COVID-19 vaccine boosters induce neutralizing immunity against SARS-CoV-2 Omicron variant. Cell. PMID 34995482 DOI: 10.1016/j.cell.2021.12.033 |
0.819 |
|
| 2022 |
Naranbhai V, St Denis KJ, Lam EC, Ofoman O, Garcia-Beltran WF, Mairena CB, Bhan AK, Gainor JF, Balazs AB, Iafrate AJ. Neutralization breadth of SARS-CoV-2 viral variants following primary series and booster SARS-CoV-2 vaccines in patients with cancer. Cancer Cell. PMID 34990570 DOI: 10.1016/j.ccell.2021.12.002 |
0.36 |
|
| 2021 |
Canaday DH, Oyebanji OA, Keresztesy D, Payne M, Wilk D, Carias L, Aung H, St Denis K, Lam EC, Rowley CF, Berry SD, Cameron CM, Cameron MJ, Wilson BM, Balazs AB, et al. Significant Reduction in Vaccine-Induced Antibody Levels and Neutralization Activity Among Healthcare Workers and Nursing Home Residents 6 Months Following Coronavirus Disease 2019 BNT162b2 mRNA Vaccination. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. PMID 35174389 DOI: 10.1093/cid/ciab963 |
0.343 |
|
| 2021 |
Calvet-Mirabent M, Claiborne DT, Deruaz M, Tanno S, Serra C, Delgado-Arévalo C, Sánchez-Cerrillo I, de Los Santos I, Sanz J, García-Fraile L, Sánchez-Madrid F, Alfranca A, Muñoz-Fernández MÁ, Allen TM, Buzón MJ, ... Balazs A, et al. Poly I:C and STING agonist-primed DC increase lymphoid tissue polyfunctional HIV-1-specific CD8 T cells and limit CD4 T cell loss in BLT mice. European Journal of Immunology. PMID 34935145 DOI: 10.1002/eji.202149502 |
0.339 |
|
| 2021 |
Garcia-Beltran WF, St Denis KJ, Hoelzemer A, Lam EC, Nitido AD, Sheehan ML, Berrios C, Ofoman O, Chang CC, Hauser BM, Feldman J, Gregory DJ, Poznansky MC, Schmidt AG, Iafrate AJ, ... ... Balazs AB, et al. mRNA-based COVID-19 vaccine boosters induce neutralizing immunity against SARS-CoV-2 Omicron variant. Medrxiv : the Preprint Server For Health Sciences. PMID 34931201 DOI: 10.1101/2021.12.14.21267755 |
0.81 |
|
| 2021 |
Canaday DH, Oyebanji OA, White E, Keresztesy D, Payne M, Wilk D, Carias L, Aung H, Denis KS, Sheehan ML, Berry SD, Cameron CM, Cameron MJ, Wilson BM, Balazs AB, et al. Significantly elevated antibody levels and neutralization titers in nursing home residents after SARS-CoV-2 BNT162b2 mRNA booster vaccination. Medrxiv : the Preprint Server For Health Sciences. PMID 34909792 DOI: 10.1101/2021.12.07.21267179 |
0.324 |
|
| 2021 |
Bowes CL, Naranbhai V, St Denis KJ, Lam EC, Bertaux B, Keane FK, Khandekar MJ, Balazs AB, Iafrate JA, Gainor JF, Willers H. Heterogeneous immunogenicity of SARS-CoV-2 vaccines in cancer patients receiving radiotherapy. Radiotherapy and Oncology : Journal of the European Society For Therapeutic Radiology and Oncology. PMID 34838892 DOI: 10.1016/j.radonc.2021.11.012 |
0.341 |
|
| 2021 |
Phelps M, Balazs AB. Contribution to HIV Prevention and Treatment by Antibody-Mediated Effector Function and Advances in Broadly Neutralizing Antibody Delivery by Vectored Immunoprophylaxis. Frontiers in Immunology. 12: 734304. PMID 34603314 DOI: 10.3389/fimmu.2021.734304 |
0.832 |
|
| 2021 |
Garcia-Beltran WF, Claiborne DT, Maldini CR, Phelps M, Vrbanac V, Karpel ME, Krupp KL, Power KA, Boutwell CL, Balazs AB, Tager AM, Altfeld M, Allen TM. Innate Immune Reconstitution in Humanized Bone Marrow-Liver-Thymus (HuBLT) Mice Governs Adaptive Cellular Immune Function and Responses to HIV-1 Infection. Frontiers in Immunology. 12: 667393. PMID 34122425 DOI: 10.3389/fimmu.2021.667393 |
0.815 |
|
| 2021 |
Canaday DH, Carias L, Oyebanji OA, Keresztesy D, Wilk D, Payne M, Aung H, St Denis K, Lam EC, Rowley CF, Berry SD, Cameron CM, Cameron MJ, Wilson B, Balazs AB, et al. Reduced BNT162b2 mRNA vaccine response in SARS-CoV-2-naive nursing home residents. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. PMID 33993265 DOI: 10.1093/cid/ciab447 |
0.305 |
|
| 2021 |
Garcia-Beltran WF, Lam EC, St Denis K, Nitido AD, Garcia ZH, Hauser BM, Feldman J, Pavlovic MN, Gregory DJ, Poznansky MC, Sigal A, Schmidt AG, Iafrate AJ, Naranbhai V, Balazs AB. Multiple SARS-CoV-2 variants escape neutralization by vaccine-induced humoral immunity. Cell. 184: 2523. PMID 33930298 DOI: 10.1016/j.cell.2021.04.006 |
0.794 |
|
| 2021 |
Canaday DH, Carias L, Oyebanji OA, Keresztesy D, Wilk D, Payne M, Aung H, Denis KS, Lam EC, Wilson B, Rowley CF, Berry SD, Cameron CM, Cameron MJ, Balazs AB, et al. Reduced BNT162b2 mRNA vaccine response in SARS-CoV-2-naive nursing home residents. Medrxiv : the Preprint Server For Health Sciences. PMID 33791727 DOI: 10.1101/2021.03.19.21253920 |
0.351 |
|
| 2021 |
Hauser BM, Sangesland M, St Denis K, Feldman J, Lam EC, Kannegieter T, Balazs AB, Lingwood D, Schmidt AG. Rationally designed immunogens enable immune focusing to the SARS-CoV-2 receptor binding motif. Biorxiv : the Preprint Server For Biology. PMID 33758851 DOI: 10.1101/2021.03.15.435440 |
0.328 |
|
| 2021 |
Garcia-Beltran WF, Lam EC, St Denis K, Nitido AD, Garcia ZH, Hauser BM, Feldman J, Pavlovic MN, Gregory DJ, Poznansky MC, Sigal A, Schmidt AG, Iafrate AJ, Naranbhai V, Balazs AB. Multiple SARS-CoV-2 variants escape neutralization by vaccine-induced humoral immunity. Cell. PMID 33743213 DOI: 10.1016/j.cell.2021.03.013 |
0.806 |
|
| 2021 |
Garcia-Beltran WF, Lam EC, Denis KS, Nitido AD, Garcia ZH, Hauser BM, Feldman J, Pavlovic MN, Gregory DJ, Poznansky MC, Sigal A, Schmidt AG, Iafrate AJ, Naranbhai V, Balazs AB. Circulating SARS-CoV-2 variants escape neutralization by vaccine-induced humoral immunity. Medrxiv : the Preprint Server For Health Sciences. PMID 33619506 DOI: 10.1101/2021.02.14.21251704 |
0.805 |
|
| 2021 |
Feldman J, Bals J, Denis KS, Lam EC, Hauser BM, Ronsard L, Sangesland M, Moreno TB, Okonkwo V, Hartojo N, Balazs AB, Lingwood D, Schmidt AG. Naive human B cells can neutralize SARS-CoV-2 through recognition of its receptor binding domain. Biorxiv : the Preprint Server For Biology. PMID 33594359 DOI: 10.1101/2021.02.02.429458 |
0.353 |
|
| 2021 |
Schiff AE, Linder AH, Luhembo SN, Banning S, Deymier MJ, Diefenbach TJ, Dickey AK, Tsibris AM, Balazs AB, Cho JL, Medoff BD, Walzl G, Wilkinson RJ, Burgers WA, Corleis B, et al. T cell-tropic HIV efficiently infects alveolar macrophages through contact with infected CD4+ T cells. Scientific Reports. 11: 3890. PMID 33594125 DOI: 10.1038/s41598-021-82066-x |
0.778 |
|
| 2020 |
Garcia-Beltran WF, Lam EC, Astudillo MG, Yang D, Miller TE, Feldman J, Hauser BM, Caradonna TM, Clayton KL, Nitido AD, Murali MR, Alter G, Charles RC, Dighe A, Branda JA, ... ... Balazs AB, et al. COVID-19-neutralizing antibodies predict disease severity and survival. Cell. PMID 33412089 DOI: 10.1016/j.cell.2020.12.015 |
0.804 |
|
| 2020 |
Kielau Kisalu N, Da Silva Pereira L, Ernste KJ, Flores-Garcia Y, Idris AH, Asokan M, Dillon M, MacDonald S, Shi W, Chen X, Pegu A, Schön A, Zavala F, Balazs AB, Francica JR, et al. Enhancing durability of CIS43 monoclonal antibody by Fc mutation or AAV delivery for malaria prevention. Jci Insight. PMID 33332286 DOI: 10.1172/jci.insight.143958 |
0.356 |
|
| 2020 |
Hauser BM, Sangesland M, Lam EC, Feldman J, Yousif AS, Caradonna TM, Balazs AB, Lingwood D, Schmidt AG. Engineered receptor binding domain immunogens elicit pan-coronavirus neutralizing antibodies. Biorxiv : the Preprint Server For Biology. PMID 33330872 DOI: 10.1101/2020.12.07.415216 |
0.364 |
|
| 2020 |
Chen Y, Zuiani A, Fischinger S, Mullur J, Atyeo C, Travers M, Lelis FJN, Pullen KM, Martin H, Tong P, Gautam A, Habibi S, Bensko J, Gakpo D, Feldman J, ... ... Balazs AB, et al. Quick COVID-19 Healers Sustain Anti-SARS-CoV-2 Antibody Production. Cell. PMID 33171099 DOI: 10.1016/j.cell.2020.10.051 |
0.415 |
|
| 2020 |
Garcia-Beltran WF, Lam EC, Astudillo MG, Yang D, Miller TE, Feldman J, Hauser BM, Caradonna TM, Clayton KL, Nitido AD, Murali MR, Alter G, Charles RC, Dighe A, Branda JA, ... ... Balazs AB, et al. COVID-19 neutralizing antibodies predict disease severity and survival. Medrxiv : the Preprint Server For Health Sciences. PMID 33106822 DOI: 10.1101/2020.10.15.20213512 |
0.807 |
|
| 2020 |
Roy V, Fischinger S, Atyeo C, Slein M, Loos C, Balazs A, Luedemann C, Astudillo MG, Yang D, Wesemann D, Charles R, Lafrate AJ, Feldman J, Hauser B, Caradonna T, et al. SARS-CoV-2-specific ELISA development. Journal of Immunological Methods. 112832. PMID 32780998 DOI: 10.1016/J.Jim.2020.112832 |
0.417 |
|
| 2020 |
Crawford KHD, Eguia R, Dingens AS, Loes AN, Malone KD, Wolf CR, Chu HY, Tortorici MA, Veesler D, Murphy M, Pettie D, King NP, Balazs AB, Bloom JD. Protocol and Reagents for Pseudotyping Lentiviral Particles with SARS-CoV-2 Spike Protein for Neutralization Assays. Viruses. 12. PMID 32384820 DOI: 10.3390/V12050513 |
0.624 |
|
| 2020 |
Keating CL, Kuhn E, Bals J, Cocco AR, Yousif AS, Matysiak C, Sangesland M, Ronsard L, Smoot M, Barcamonte Moreno T, Okonkwo V, Setliff I, Georgiev I, Balazs AB, Carr SA, et al. Spontaneous glycan reattachment following N-glycanase treatment of influenza and HIV vaccine antigens. Journal of Proteome Research. PMID 31913636 DOI: 10.1021/Acs.Jproteome.9B00620 |
0.402 |
|
| 2019 |
Huang Q, Chan KY, Tobey IG, Chan YA, Poterba T, Boutros CL, Balazs AB, Daneman R, Bloom JM, Seed C, Deverman BE. Delivering genes across the blood-brain barrier: LY6A, a novel cellular receptor for AAV-PHP.B capsids. Plos One. 14: e0225206. PMID 31725765 DOI: 10.1371/Journal.Pone.0225206 |
0.584 |
|
| 2019 |
van den Berg FT, Makoah NA, Ali SA, Scott TA, Mapengo RE, Mutsvunguma LZ, Mkhize NN, Lambson BE, Kgagudi PD, Crowther C, Abdool Karim SS, Balazs AB, Weinberg MS, Ely A, Arbuthnot PB, et al. AAV-Mediated Expression of Broadly Neutralizing and Vaccine-like Antibodies Targeting the HIV-1 Envelope V2 Region. Molecular Therapy. Methods & Clinical Development. 14: 100-112. PMID 31334303 DOI: 10.1016/J.Omtm.2019.06.002 |
0.634 |
|
| 2018 |
Welles HC, Jennewein MF, Mason RD, Narpala S, Wang L, Cheng C, Zhang Y, Todd JP, Lifson JD, Balazs AB, Alter G, McDermott AB, Mascola JR, Roederer M. Vectored delivery of anti-SIV envelope targeting mAb via AAV8 protects rhesus macaques from repeated limiting dose intrarectal swarm SIVsmE660 challenge. Plos Pathogens. 14: e1007395. PMID 30517201 DOI: 10.1371/Journal.Ppat.1007395 |
0.529 |
|
| 2018 |
Lin A, Balazs AB. Adeno-associated virus gene delivery of broadly neutralizing antibodies as prevention and therapy against HIV-1. Retrovirology. 15: 66. PMID 30285769 DOI: 10.1186/S12977-018-0449-7 |
0.805 |
|
| 2017 |
Brady JM, Baltimore D, Balazs AB. Antibody gene transfer with adeno-associated viral vectors as a method for HIV prevention. Immunological Reviews. 275: 324-333. PMID 28133808 DOI: 10.1111/Imr.12478 |
0.832 |
|
| 2015 |
Akkina RK, Allam A, Balazs AB, Blankson J, Burnett JC, Casares S, Garcia JV, Hasenkrug K, Kashanchi F, Kitchen S, Klein F, Kumar P, Luster AD, Poluektova LY, Rao M, et al. Improvements and Limitations of Humanized Mouse Models for HIV Research: NIH/NIAID "Meet the Experts" 2015 Workshop Summary. Aids Research and Human Retroviruses. PMID 26670361 DOI: 10.1089/Aid.2015.0258 |
0.46 |
|
| 2015 |
Deal CE, Balazs AB. Engineering humoral immunity as prophylaxis or therapy. Current Opinion in Immunology. 35: 113-22. PMID 26183209 DOI: 10.1016/J.Coi.2015.06.014 |
0.831 |
|
| 2015 |
Saunders KO, Wang L, Joyce MG, Yang ZY, Balazs AB, Cheng C, Ko SY, Kong WP, Rudicell RS, Georgiev IS, Duan L, Foulds KE, Donaldson M, Xu L, Schmidt SD, et al. Broadly neutralizing human immunodeficiency virus type 1 antibody gene transfer protects non-human primates from mucosal simian-human immunodeficiency virus infection. Journal of Virology. PMID 26041300 DOI: 10.1128/Jvi.00908-15 |
0.728 |
|
| 2015 |
Deal CE, Balazs AB. Vectored antibody gene delivery for the prevention or treatment of HIV infection. Current Opinion in Hiv and Aids. 10: 190-7. PMID 25700206 DOI: 10.1097/Coh.0000000000000145 |
0.832 |
|
| 2014 |
de Jong YP, Dorner M, Mommersteeg MC, Xiao JW, Balazs AB, Robbins JB, Winer BY, Gerges S, Vega K, Labitt RN, Donovan BM, Giang E, Krishnan A, Chiriboga L, Charlton MR, et al. Broadly neutralizing antibodies abrogate established hepatitis C virus infection. Science Translational Medicine. 6: 254ra129. PMID 25232181 DOI: 10.1126/Scitranslmed.3009512 |
0.596 |
|
| 2014 |
Deal C, Balazs AB, Espinosa DA, Zavala F, Baltimore D, Ketner G. Vectored antibody gene delivery protects against Plasmodium falciparum sporozoite challenge in mice. Proceedings of the National Academy of Sciences of the United States of America. 111: 12528-32. PMID 25114213 DOI: 10.1073/Pnas.1407362111 |
0.804 |
|
| 2014 |
Balazs AB, Ouyang Y, Hong CM, Chen J, Nguyen SM, Rao DS, An DS, Baltimore D. Vectored immunoprophylaxis protects humanized mice from mucosal HIV transmission. Nature Medicine. 20: 296-300. PMID 24509526 DOI: 10.1038/Nm.3471 |
0.784 |
|
| 2014 |
Deal C, Ouyang Y, Hong CM, An DS, Baltimore D, Balazs AB. Durable Suppression of Established Transmitted Founder Replication in Infected BLT Humanized Mice by Vectored ImmunoTherapy Aids Research and Human Retroviruses. 30: A16-A17. DOI: 10.1089/Aid.2014.5018.Abstract |
0.665 |
|
| 2013 |
Balazs AB, Bloom JD, Hong CM, Rao DS, Baltimore D. Broad protection against influenza infection by vectored immunoprophylaxis in mice. Nature Biotechnology. 31: 647-52. PMID 23728362 DOI: 10.1038/Nbt.2618 |
0.779 |
|
| 2013 |
Balazs AB, West AP. Antibody gene transfer for HIV immunoprophylaxis. Nature Immunology. 14: 1-5. PMID 23238748 DOI: 10.1038/Ni.2480 |
0.558 |
|
| 2013 |
de Jong Y, Dorner M, Balazs A, Robbins J, Labitt R, Donovan B, Krishnan A, Charlton M, Chiriboga L, Burton D, Rice C, Baltimore D, Law M, Ploss A. 1146 THE EFFECTS OF BROADLY NEUTRALIZING ANTIBODIES IN EXPERIMENTAL HCV INFECTION Journal of Hepatology. 58: S466-S467. DOI: 10.1016/S0168-8278(13)61147-2 |
0.556 |
|
| 2012 |
Balazs AB, Chen J, Hong CM, Rao DS, Yang L, Baltimore D. Antibody-based protection against HIV infection by vectored immunoprophylaxis. Nature. 481: 81-4. PMID 22139420 DOI: 10.1038/Nature10660 |
0.827 |
|
| 2011 |
Sigal A, Kim JT, Balazs AB, Dekel E, Mayo A, Milo R, Baltimore D. Cell-to-cell spread of HIV permits ongoing replication despite antiretroviral therapy. Nature. 477: 95-8. PMID 21849975 DOI: 10.1038/Nature10347 |
0.648 |
|
| 2010 |
Luo XM, Lei MY, Feidi RA, West AP, Balazs AB, Bjorkman PJ, Yang L, Baltimore D. Dimeric 2G12 as a potent protection against HIV-1. Plos Pathogens. 6: e1001225. PMID 21187894 DOI: 10.1371/Journal.Ppat.1001225 |
0.73 |
|
| 2010 |
O'Connell RM, Balazs AB, Rao DS, Kivork C, Yang L, Baltimore D. Lentiviral vector delivery of human interleukin-7 (hIL-7) to human immune system (HIS) mice expands T lymphocyte populations. Plos One. 5: e12009. PMID 20700454 DOI: 10.1371/Journal.Pone.0012009 |
0.734 |
|
| 2010 |
O'Connell RM, Chaudhuri AA, Rao DS, Gibson WS, Balazs AB, Baltimore D. MicroRNAs enriched in hematopoietic stem cells differentially regulate long-term hematopoietic output. Proceedings of the National Academy of Sciences of the United States of America. 107: 14235-40. PMID 20660734 DOI: 10.1073/Pnas.1009798107 |
0.7 |
|
| 2008 |
Austin KM, Gupta ML, Coats SA, Tulpule A, Mostoslavsky G, Balazs AB, Mulligan RC, Daley G, Pellman D, Shimamura A. Mitotic spindle destabilization and genomic instability in Shwachman-Diamond syndrome. The Journal of Clinical Investigation. 118: 1511-8. PMID 18324336 DOI: 10.1172/Jci33764 |
0.648 |
|
| 2006 |
Balazs AB, Fabian AJ, Esmon CT, Mulligan RC. Endothelial protein C receptor (CD201) explicitly identifies hematopoietic stem cells in murine bone marrow. Blood. 107: 2317-21. PMID 16304059 DOI: 10.1182/Blood-2005-06-2249 |
0.597 |
|
| 2004 |
Michurina T, Krasnov P, Balazs A, Nakaya N, Vasilieva T, Kuzin B, Khrushchov N, Mulligan RC, Enikolopov G. Nitric oxide is a regulator of hematopoietic stem cell activity. Molecular Therapy : the Journal of the American Society of Gene Therapy. 10: 241-8. PMID 15294171 DOI: 10.1016/J.Ymthe.2004.05.030 |
0.586 |
|
| Show low-probability matches. |
